Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01830842 · ClinicalTrials.gov registry record · NA
Acute and Chronic Nicotine Modulation of Reinforcement Learning
A NA study of Nicotine Addiction, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
- 1
- Study location
NCT01830842 is a NA study of Nicotine Addiction that has completed, run by Duke University. The registered enrollment target is 54 participants, below the 719-participant average among 10 other Nicotine Addiction trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01830842, a NA study of Nicotine Addiction, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to use functional magnetic resonance imaging (fMRI) to investigate the acute and chronic effects of nicotine on motivational behavior and prediction error-related neural activation. Nonsmokers (n = 24) and smokers (n = 24) will undergo fMRI scans on two separate occasions while performing a decision-making task that will elicit prediction error signals in the mesocorticolimbic pathway of the brain. Nonsmokers will be scanned once following an acute dose of nicotine and once following placebo administration. Smokers will be scanned once following smoking as usual and once following 24-hours of smoking abstinence, in order to measure the effects of nicotine withdrawal. The study team hypothesizes that acute nicotine will increase the prediction error signal in nonsmokers compared to placebo, and that nicotine withdrawal will decrease the prediction error signal in smokers compared to the normal satiated condition. Furthermore, nonsmokers (during the placebo condition) will have greater prediction error activation than smokers (during the satiated condition). The results of this study will inform whether the initiation and maintenance of smoking behavior could be facilitated by the effects of nicotine on reinforcement learning.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Nicotine polacrilex
- OTHER satiety
- OTHER abstinence
Study Locations (1)
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2014-02 |
| Est. Completion | 2016-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01830842
The ClinicalTrials.gov registry entry for NCT01830842 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 719-participant average among 10 other Nicotine Addiction trials with a reported enrollment target (92% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nicotine Addiction appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.
NCT01830842 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT01830842 about?
NCT01830842 is a clinical study titled "Acute and Chronic Nicotine Modulation of Reinforcement Learning". The purpose of this study is to use functional magnetic resonance imaging (fMRI) to investigate the acute and chronic effects of nicotine on motivational behavior and prediction error-related neural activation. Nonsmokers (n = 24) and smokers (n = 24) will undergo fMRI scans on two separate occasion...
What is the current status of trial NCT01830842?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2014-02. Estimated completion is 2016-08-31.
What conditions does trial NCT01830842 study?
This clinical trial studies the following conditions: Nicotine Addiction.
What interventions are being tested in trial NCT01830842?
The interventions under investigation include: Placebo (DRUG), Nicotine polacrilex (DRUG), satiety (OTHER), abstinence (OTHER).
Who is sponsoring clinical trial NCT01830842?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01830842 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Addiction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Product Characteristics on the Abuse Liability of Nicotine Pouches
RECRUITING · NA
-
CONNECT Cancer Survivors With Tobacco Treatment
RECRUITING · NA
-
Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)
RECRUITING · NA
-
Cognitive Training for Nicotine Dependence
COMPLETED · NA
-
Effects of Brief Training on Craving Regulation
COMPLETED · NA
-
Computer-Facilitated 5A's for Smoking Cessation in Primary Care
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.